AI in Pharma
Article
The Deployment of Elsa at the FDA: Regulatory Concerns, Potential Consequences, and a Path Forward
A critical look at FDA’s AI rollout, its pitfalls, and a SMART framework for responsible regulatory AI in life sciences.
Other latest pieces about AI in Pharma you may like to read
The Deployment of Elsa at the FDA: Regulatory Concerns, Potential Consequences, and a Path Forward
A critical look at FDA’s AI rollout, its pitfalls, and a SMART framework for responsible regulatory AI in life sciences.
by Dr. Ajaz Hussain & Mr. Ram Balani
Artificial Intelligence and Machine Learning Transforming Drug Discovery
How AI and ML are reshaping the drug discovery process by improving speed, accuracy, and efficiency.
by Snigdha Joshi
Using Big Data in Pharmacovigilance: Insights on Data Mining for Drug Safety
Explore how data mining is transforming pharmacovigilance by predicting adverse drug events and interactions for better patient safety.
by Snigdha Joshi
Digital Twins: Reshaping the Pharmaceutical Sector
Explore how digital twins are revolutionizing pharma manufacturing, clinical trials, and personalized medicine for efficiency and innovation.
by Michael Bani
Moving Towards Good Linguistic Practices in AI-Assisted Regulatory Communications
Explore AI in pharma regulatory communications! Learn how SmartSearch+ & RAG improve accuracy, compliance & decision-making.
by Ram Balani, MBA, Abdulaziz A. AlSayyari, Ph.D. MBA and Ajaz S. Hussian, Ph.D.
